Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997

Larry D. Cripe, Kevin Rader, Martin S. Tallman, Michael S. Gordon, Elisabeth Paietta, John Bennett, Donna Neuberg, Mark R. Litzow, Timothy E. O'Brien, Jacob M. Rowe

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997'. Together they form a unique fingerprint.

Medicine & Life Sciences